EDUCATIONAL LECTURE ON TREATMENT OF PARKINSON DISEASE
نویسندگان
چکیده
منابع مشابه
Surgical treatment for Parkinson disease
Since the beginning of neurosurgery, operations have been carried out throughout the central nervous system to treat movement disorders. In the 1930's and 1940's, early neurosurgical procedures focused on pyramidal tract lesions for tremor resolutions, but tremor reduction came only at the expense of motor weakness. The era of basal ganglia surgery for Parkinson's disease (PD) began when Meyers...
متن کاملP 114: The Impact of Chamomile on Parkinson Disease (PD)
After Alzheimer disease, Parkinson disease (PD) is considered the most common neurodegenerative disease. Its prevalence is the same in all area but it is common in males than females. From every 100 persons who are above 60 years old, one of them has PD. Also 5-10% of patients are less than 40 years old. This progressive neuroinflammation disease isn’t fatal. In 60% of cases is with depre...
متن کاملEducational Lecture
― ― S30 ― US FDA is a regulatory body to regulate not only drugs but also medical devices, biological products, cell therapy products, cosmetics and food additives. The largest laboratory animal users are laboratories that follow the government requirement for safety testing and the amendment of GLP regulation is interested in by laboratory animal industry. In USA, GLP is regulated by law inste...
متن کاملAn update on the diagnosis and treatment of Parkinson disease.
© 2016 Joule Inc. or its licensors CMAJ 1 Competing interests: Mandar Jog reports honoraria from Merz Pharmaceuticals, Allergan and AbbVie; and grants from the Canadian Institutes of Health Research, Academic Medical Organization of Southwestern Ontario, Lawson Health Research Institute, AGE-WELL Networks of Centres of Excellence, Merz Pharmaceuticals and Boston Scientific. He occasionally serv...
متن کاملPharmacological treatment of Parkinson disease: a review.
IMPORTANCE Parkinson disease is the second most common neurodegenerative disease worldwide. Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies can improve patient quality of life. OBJECTIVE To provide an evidence-based review of the initial pharmacological management of the classic motor symptoms of Parkinson disease; describe management of m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 1982
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.71.1217